Differential suppressive effect of promyelocytic leukemia protein on the replication of different subtypes/strains of influenza A virus

Biochemical and Biophysical Research Communications

Volumn 389, Issue 1, 2009, Pages 84-89

  Li, Weizhong ^a,b   Wang, Gefei ^b   Zhang, Heng ^b   Zhang, Dangui ^b   Zeng, Jun ^b   Chen, Xiaoxuan ^b   Xu, Yanxuan ^b   Li, Kangsheng ^b  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Influenza A virus; Promyelocytic leukemia protein; Replication

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CELL STRAIN; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFECTION RESISTANCE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H9N2; KNOCKOUT GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RNA INTERFERENCE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CELL LINE, TUMOR; DOGS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H9N2 SUBTYPE; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VIRUS REPLICATION;

INFLUENZA A VIRUS;

EID: 70349088547     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.091     Document Type: Article

References (29)

1. Nelson M.I., Viboud C., Simonsen L., Bennett R.T., Griesemer S.B., St. George K., Taylor J., Spiro D.J., Sengamalay N.A., Ghedin E., Taubenberger J.K., and Holmes E.C. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog. 4 (2008) e1000012
2. Li K.S., Xu K.M., Peiris J.S., Poon L.L., Yu K.Z., Yuen K.Y., Shortridge K.F., Webster R.G., and Guan Y. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans?. J. Virol. 77 (2003) 6988-6994
3. Peiris M., Yuen K.Y., Leung C.W., Chan K.H., Ip P.L., Lai R.W., Orr W.K., and Shortridge K.F. Human infection with influenza H9N2. Lancet 354 (1999) 916-917
4. Chelbi-Alix M.K., Quignon F., Pelicano L., Koken M.H., and de The H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72 (1998) 1043-1051
5. Iki S., Yokota S., Okabayashi T., Yokosawa N., Nagata K., and Fujii N. Serum-dependent expression of promyelocytic leukemia protein suppresses propagation of influenza virus. Virology 343 (2005) 106-115
6. Terris B., Baldin V., Dubois S., Degott C., Flejou J.F., Henin D., and Dejean A. PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55 (1995) 1590-1597
7. Zhong S., Salomoni P., and Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2 (2000) E85-E90
8. Wang Z.G., Ruggero D., Ronchetti S., Zhong S., Gaboli M., Rivi R., and Pandolfi P.P. PML is essential for multiple apoptotic pathways. Nat. Genet. 20 (1998) 266-272
9. Jensen K., Shiels C., and Freemont P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20 (2001) 7223-7233
10. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., and Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 20 (2001) 2140-2151
11. Dittmann J., Stertz S., Grimm D., Steel J., Garcia-Sastre A., Haller O., and Kochs G. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J. Virol. 82 (2008) 3624-3631
12. Stadler M., Chelbi-Alix M.K., Koken M.H., Venturini L., Lee C., Saib A., Quignon F., Pelicano L., Guillemin M.C., Schindler C., et al. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene 11 (1995) 2565-2573
13. Hayman A., Comely S., Lackenby A., Murphy S., McCauley J., Goodbourn S., and Barclay W. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347 (2006) 52-64
14. Uetani K., Hiroi M., Meguro T., Ogawa H., Kamisako T., Ohmori Y., and Erzurum S.C. Influenza A virus abrogates IFN-gamma response in respiratory epithelial cells by disruption of the Jak/Stat pathway. Eur. J. Immunol. 38 (2008) 1559-1573
15. Geiss G.K., Salvatore M., Tumpey T.M., Carter V.S., Wang X., Basler C.F., Taubenberger J.K., Bumgarner R.E., Palese P., Katze M.G., and Garcia-Sastre A. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 99 (2002) 10736-10741
16. Condemine W., Takahashi Y., Zhu J., Puvion-Dutilleul F., Guegan S., Janin A., and de The H. Characterization of endogenous human promyelocytic leukemia isoforms. Cancer Res. 66 (2006) 6192-6198
17. Ahn J.H., and Hayward G.S. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274 (2000) 39-55
18. Doucas V., Ishov A.M., Romo A., Juguilon H., Weitzman M.D., Evans R.M., and Maul G.G. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10 (1996) 196-207
19. Engelhardt O.G., Sirma H., Pandolfi P.P., and Haller O. Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. J. Gen. Virol. 85 (2004) 2315-2326
20. Blondel D., Regad T., Poisson N., Pavie B., Harper F., Pandolfi P.P., De The H., and Chelbi-Alix M.K. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21 (2002) 7957-7970
21. Asper M., Sternsdorf T., Hass M., Drosten C., Rhode A., Schmitz H., and Gunther S. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J. Virol. 78 (2004) 3162-3169
22. Bonilla W.V., Pinschewer D.D., Klenerman P., Rousson V., Gaboli M., Pandolfi P.P., Zinkernagel R.M., Salvato M.S., and Hengartner H. Effects of promyelocytic leukemia protein on virus-host balance. J. Virol. 76 (2002) 3810-3818
23. Pampin M., Simonin Y., Blondel B., Percherancier Y., and Chelbi-Alix M.K. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J. Virol. 80 (2006) 8582-8592
24. Chelbi-Alix M.K., and de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18 (1999) 935-941
25. Lopez P., Jacob R.J., and Roizman B. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins. J. Virol. 76 (2002) 9355-9367
26. Everett R.D., and Zafiropoulos A. Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection. J. Virol. 78 (2004) 11411-11415
27. McNally B.A., Trgovcich J., Maul G.G., Liu Y., and Zheng P. A role for cytoplasmic PML in cellular resistance to viral infection. PLoS One 3 (2008) e2277
28. Borden K.L., Campbell Dwyer E.J., and Salvato M.S. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J. Virol. 72 (1998) 758-766
29. Adamson A.L., and Kenney S. Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J. Virol. 75 (2001) 2388-2399